Silicon Laboratories Inc. — Form 10-Q Summary
Period and scope: The filing covers the 13 weeks ended April 2, 2022 (fiscal Q1 2022), with comparisons to the three months ended April 3, 2021. The request metadata says “2021 Q1,” but the filing itself is for 2022 Q1. Dollar amounts below are in millions unless stated otherwise. The 2021 comparison includes the former infrastructure and automotive business as discontinued operations; continuing-operations comparisons are more informative for the ongoing business.
Financial results and liquidity
| Metric | Q1 2022 | Comparable 2021 | Change / context |
|---|---|---|---|
| Continuing revenue | $233.8 | $157.9 | Up 48.1%; average selling prices rose substantially and unit volumes increased slightly. |
| Gross profit / margin | $155.8 / 66.6% | $91.8 / 58.1% | Margin expanded 8.5 percentage points, attributed to product mix and higher prices. |
| Operating income (loss) | $33.6 | $(14.7) | Improved by $48.3. |
| Continuing net income (loss) | $22.9 | $(25.2) | Diluted continuing EPS was $0.58 versus $(0.57). |
| Net income, including discontinued operations | $22.9 | $13.5 | Prior-year net income included $38.7 of after-tax discontinued-operations income. |
| Operating cash flow, continuing operations | $85.2 | $(20.3) | Improved; working-capital movements provided a net cash inflow. |
| Cash and short-term investments | $1,933.7 | — | At April 2, 2022; cash and equivalents were $765.9 and short-term investments $1,167.8. |
| Debt | $528.1 carrying value | — | $535.0 principal amount of 0.625% convertible notes due 2025; $400 revolving facility undrawn. |
R&D expense was $77.5, up 21.1%, primarily from personnel costs; SG&A was $44.6, up 5.2%. Together, operating expenses were $122.2 versus $106.5. Interest expense fell to $1.7 from $11.3, mainly because adoption of ASU 2020-06 ended debt-discount amortization and the prior-year period included a debt-extinguishment loss. The effective tax rate was 33.8%, compared with (8.6)%; the company cited new U.S. rules requiring capitalization and amortization of research and experimental costs, as well as tax benefits recorded in discontinued operations in the prior period.
Cash and cash equivalents declined $308.7 during the quarter. Investing activities used $217.4, principally reflecting net purchases of marketable securities; financing activities used $166.5, including $157.8 of cash for share repurchases. The company reported acquiring 1.419 million shares for $163.8 in the quarter. DSO was 30 days, down from 42 days at fiscal year-end; inventory was $55.5, or 64 days, up from 55 days.
Business changes and management commentary
- Industrial & Commercial revenue rose to $126.7 from $78.7 (60.9%); Home & Life revenue increased to $107.1 from $79.1 (35.4%).
- The 2021 sale of the infrastructure and automotive business to Skyworks for $2.75 billion closed July 26, 2021. Its prior-year results are presented as discontinued operations. Transition-services fees from Skyworks were approximately $1.9 in Q1 2022.
- The company introduced a family of 2.4 GHz wireless SoCs with a built-in AI/ML accelerator for Bluetooth and multiprotocol applications.
- Two distributors, Arrow Electronics and Edom Technology, each represented more than 10% of revenue; distributors accounted for 82% of revenue. No individual customer represented more than 10%. 84% of revenue was from outside the United States.
- Adoption of ASU 2020-06 on January 2, 2022 reduced retained earnings by $60.0 through a cumulative-effect adjustment and changed the accounting presentation of the convertible notes. The adoption reduced Q1 interest expense and increased basic and diluted EPS by $0.11 and $0.10, respectively.
- The board increased the share-repurchase authorization from $250 to $600 in April 2022; the expanded authorization is subsequent to quarter-end.
Outlook, risks, and contingencies
Management’s Q2 fiscal 2022 outlook: revenue of $245–$255; gross margin of 60.9%; operating expenses of $129; effective tax rate of 33%; and diluted EPS of $0.37–$0.47. Management expected R&D and SG&A expenses to increase in absolute dollars in Q2. It also expected inventory costs to rise in future periods, which could reduce gross margin.
- Supply and demand: The company reported limited foundry, assembly, and test capacity and longer lead times amid elevated semiconductor demand. It relies on third parties, primarily in Asia, and generally lacks long-term supply commitments. Capacity constraints, production yields, or customer demand changes could affect shipments, costs, and margins.
- Market and operating risks: Risks include semiconductor cyclicality, pricing and product-mix volatility, customer and distributor concentration, lengthy sales and qualification cycles, inventory obsolescence, competition, and dependence on successful new-product development. COVID-19, geopolitical events, trade restrictions, and cyber incidents could disrupt suppliers, customers, or operations.
- Debt and liquidity: The $535.0 principal amount of 2025 notes is intended to be settled in cash for principal and shares for any excess conversion value. The company said it believed liquidity and operating cash generation were sufficient for at least 12 months. It reported compliance with credit-facility covenants and no revolver borrowings.
- Tax matter: The company is appealing a Norwegian tax assessment concerning 2013 intercompany pricing, estimated at 141.3 million Norwegian kroner, or $16.1. Management believes its position is more likely than not to be sustained, but an unfavorable outcome could materially affect the financial statements. Gross unrecognized tax benefits, including interest, were $4.1.
- Investments and legal proceedings: Auction-rate securities had $6.0 par value and $4.9 fair value and remain illiquid; the filing says the company cannot predict whether funds will become available before their 2046 maturity. The company said ordinary-course legal proceedings were not expected to have a material adverse effect.
Most important facts for investors to verify
- Whether Q2 revenue and EPS guidance is achieved, and whether the projected gross-margin decline reflects rising inventory costs, mix, or pricing changes.
- Whether constrained third-party manufacturing and testing capacity improves, and whether supply availability supports shipment growth without further cost pressure.
- Whether the elevated revenue concentration through distributors persists, including the reported 49% of revenue from the two largest distributors.
- The cash impact and resolution of the Norwegian tax appeal, and the status and liquidity of the auction-rate securities.
- Cash requirements for the 2025 convertible notes, including any conversion-related share dilution, and the pace and funding of expanded share repurchases.
- How to interpret year-over-year earnings: continuing operations improved materially, while prior-year reported net income included $38.7 of income from the business subsequently sold.